Catalyst Wire Dossier Catalyst Wire Dossier

Anti-VEGF therapy (class)

anti-VEGF agent
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-VEGF therapy (class), covering 2025-09-12 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification [Phase 4]

See pricing